Natriumklorid "Baxter" 9 mg/ml infusionsvæske, opløsning Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

natriumklorid "baxter" 9 mg/ml infusionsvæske, opløsning

baxter a/s - natriumchlorid - infusionsvæske, opløsning - 9 mg/ml

Natriumklorid "Baxter" Clear-Flex 9 mg/ml infusionsvæske, opløsning Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

natriumklorid "baxter" clear-flex 9 mg/ml infusionsvæske, opløsning

baxter a/s - natriumchlorid - infusionsvæske, opløsning - 9 mg/ml

Natriumklorid "Fresenius Kabi" 9 mg/ml infusionsvæske, opløsning Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

natriumklorid "fresenius kabi" 9 mg/ml infusionsvæske, opløsning

fresenius kabi ab - natriumchlorid - infusionsvæske, opløsning - 9 mg/ml

Evrenzo Europese Unie - Deens - EMA (European Medicines Agency)

evrenzo

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianemiske præparater - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

Reblozyl Europese Unie - Deens - EMA (European Medicines Agency)

reblozyl

bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - andre præparater antianemic - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.

Eurartesim Europese Unie - Deens - EMA (European Medicines Agency)

eurartesim

alfasigma s.p.a. - piperaquine tetraphosphate, artenimol - malaria - antiprotozomidler - eurartesim er indiceret til behandling af ukompliceret plasmodium falciparum malaria hos voksne, børn og spædbørn 6 måneder og derover og vejer 5 kg eller derover. det bør overvejes at officielle vejledning om hensigtsmæssig brug af malaria agenter.

Cisordinol Depot 200 mg/ml injektionsvæske, opløsning Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

cisordinol depot 200 mg/ml injektionsvæske, opløsning

h. lundbeck a/s - zuclopenthixoldecanoat - injektionsvæske, opløsning - 200 mg/ml

Contalgin 100 mg depotgranulat til oral suspension, enkeltdosisbeholder Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

contalgin 100 mg depotgranulat til oral suspension, enkeltdosisbeholder

pfizer aps - morphinsulfat - depotgranulat til oral suspension, enkeltdosisbeholder - 100 mg

Contalgin 200 mg depotgranulat til oral suspension, enkeltdosisbeholder Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

contalgin 200 mg depotgranulat til oral suspension, enkeltdosisbeholder

pfizer aps - morphinsulfat - depotgranulat til oral suspension, enkeltdosisbeholder - 200 mg

Contalgin 20 mg depotgranulat til oral suspension, enkeltdosisbeholder Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

contalgin 20 mg depotgranulat til oral suspension, enkeltdosisbeholder

pfizer aps - morphinsulfat - depotgranulat til oral suspension, enkeltdosisbeholder - 20 mg